HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,142,000 | +41.3% | 61,218 | +32.9% | 0.00% | +33.3% |
| Q4 2015 | $1,516,000 | -74.6% | 46,052 | -75.0% | 0.00% | -72.7% |
| Q3 2015 | $5,962,000 | -35.8% | 184,494 | -17.8% | 0.01% | -26.7% |
| Q2 2015 | $9,287,000 | +69.9% | 224,577 | +84.6% | 0.02% | +50.0% |
| Q1 2015 | $5,466,000 | +14.5% | 121,677 | -4.6% | 0.01% | +25.0% |
| Q4 2014 | $4,774,000 | -43.7% | 127,569 | -47.5% | 0.01% | -46.7% |
| Q3 2014 | $8,487,000 | +1.6% | 243,032 | +2.7% | 0.02% | 0.0% |
| Q2 2014 | $8,350,000 | +11.1% | 236,714 | +2.7% | 0.02% | +15.4% |
| Q1 2014 | $7,514,000 | +14.1% | 230,581 | +33.3% | 0.01% | +8.3% |
| Q4 2013 | $6,587,000 | -5.8% | 172,952 | -1.4% | 0.01% | 0.0% |
| Q3 2013 | $6,994,000 | -22.8% | 175,382 | -20.0% | 0.01% | -29.4% |
| Q2 2013 | $9,059,000 | – | 219,105 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |